Portage Biotech Enters Cooperative Research and Development Agreement with US National Cancer Institute and Stimunity

Portage Biotech, Inc. announced that it has entered a Cooperative Research and Development Agreement with the National Cancer Institute and Stimunity, S.A.S, an affiliate of Portage with experience in the preclinical development of stimulator of interferon genes agonists for cancer immunotherapy and infectious diseases.